XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Other Financial Information
9 Months Ended
Jun. 30, 2023
Other Financial Information.  
Other Financial Information

13.   Other Financial Information

Accrued expenses and other current liabilities consist of the following:

    

June 30, 

    

September 30, 

2023

2022

(in millions)

Accrued salaries and benefits

$

568.1

$

602.2

Accrued contract costs

 

1,279.2

1,246.0

Other accrued expenses

 

374.7

333.2

Total

$

2,222.0

$

2,181.4

Accrued contract costs above include balances related to professional liability accruals of $717.0 million and $713.6 million as of June 30, 2023 and September 30, 2022, respectively. The remaining accrued contract costs primarily relate to costs for services provided by subcontractors and other non-employees. Liabilities recorded related to accrued contract losses were not material as of June 30, 2023 and September 30, 2022. The Company did not have material revisions to estimates for contracts where revenue is recognized using the input method during the nine months ended June 30, 2023 and 2022. During the first nine months of fiscal 2023, the Company incurred restructuring expenses of $50.5 million, including personnel and other costs of $41.9 million and real estate costs of $8.6 million, of which $28.3 million was accrued and unpaid at June 30, 2023. During the first nine months of fiscal 2022, the Company incurred restructuring expenses of $88.9 million, of which $69.1 million was related to the exit of our Russia-related businesses. The remaining $19.8 million related to actions to improve margins and deliver efficiencies. These expenses included personnel and other costs of $16.5 million and real estate costs of $3.3 million, of which $1.1 million was accrued and unpaid at June 30, 2022.

On March 1, 2023, the Company’s Board of Directors declared a quarterly cash dividend of $0.18 per share, which was paid on April 21, 2023 to stockholders of record as of April 5, 2023. As of June 30, 2023, accrued and unpaid dividends totaled $26.8 million and were classified within other accrued expenses on the consolidated balance sheet.